Literature DB >> 21352118

The promise of early intervention.

Jean Addington1.   

Abstract

The focus of this review is the research and clinical work in early psychosis and early intervention which over the past 10-15 years has had a tremendous impact on the field of schizophrenia. Unparalleled progress has been made in programme and service development with a wide range of reported research results, outcome studies, treatment approaches and new initiatives. Traditional areas are being explored in the first episode that can add to our knowledge of schizophrenia. New areas that have a specific relevance for early intervention such as the duration of untreated psychosis and pathways to care are being widely studied. Despite the criticism of the lack of randomized controlled trials, there is a wealth of positive outcome from both effectiveness studies and limited controlled trials. However, there are still many unanswered issues which are in developing stages or which require further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 21352118     DOI: 10.1111/j.1751-7893.2007.00043.x

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  14 in total

1.  A stitch in time.

Authors:  Helen Lester
Journal:  Br J Gen Pract       Date:  2010-01       Impact factor: 5.386

Review 2.  A systematic review and meta-analysis of recovery in schizophrenia.

Authors:  Erika Jääskeläinen; Pauliina Juola; Noora Hirvonen; John J McGrath; Sukanta Saha; Matti Isohanni; Juha Veijola; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

3.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

4.  Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis.

Authors:  Kyaw Sint; Robert Rosenheck; Delbert G Robinson; Nina R Schooler; Patricia Marcy; John M Kane; Kim T Mueser; Haiqun Lin
Journal:  Schizophr Res       Date:  2017-08-25       Impact factor: 4.939

5.  Lessons Learned in Clinical Research Recruitment of Immigrants and Minority Group Members with First-Episode Psychosis.

Authors:  Mercedes Hernandez; Richard Franco; Alex Kopelowicz; Maria Y Hernandez; Yesenia Mejia; Concepción Barrio; Steven Regeser López
Journal:  J Immigr Minor Health       Date:  2019-02

6.  Family processes and duration of untreated psychosis among US Latinos.

Authors:  Mercedes Hernandez; Maria Y Hernandez; Daisy Lopez; Concepción Barrio; Diana Gamez; Steven R López
Journal:  Early Interv Psychiatry       Date:  2019-01-15       Impact factor: 2.732

7.  Identifying a treatable psychosis-risk cohort.

Authors:  Jean Addington
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

8.  EARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA.

Authors:  Michael T Compton; Sandra M Goulding; Claire E Ramsay; Jean Addington; Cheryl Corcoran; Elaine F Walker
Journal:  Clin Neuropsychiatry       Date:  2008-12

9.  Impact of Trauma on Attenuated Psychotic Symptoms.

Authors:  Erin Falukozi; Jean Addington
Journal:  Psychosis       Date:  2012

10.  Development of a Boston Treatment Program for Youth at Clinical High Risk for Psychosis: Center for Early Detection, Assessment, and Response to Risk (CEDAR).

Authors:  Michelle S Friedman-Yakoobian; Michelle L West; Kristen A Woodberry; Keira E O'Donovan; Suzannah V Zimmet; Andréa Gnong-Granato; Anthony J Giuliano; Margaret E Guyer; Janine Rodenhiser-Hill; Matcheri S Keshavan; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2018 Sep/Oct       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.